Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Buy
1,078
+103
+11% +$27.1K 0.02% 562
2026
Q1
$260K Buy
+975
New +$264K 0.02% 538
2025
Q4
Sell
-743
Closed -$214K 662
2025
Q3
$214K Buy
+743
New +$199K 0.01% 596
2022
Q1
Sell
-8,054
Closed -$2.17M 547
2021
Q4
$2.17M Buy
8,054
+93
+1% +$23K 0.17% 136
2021
Q3
$1.93M Buy
7,961
+6
+0.1% +$1.51K 0.17% 126
2021
Q2
$1.89M Sell
7,955
-186
-2% -$42.4K 0.17% 135
2021
Q1
$1.78M Buy
8,141
+3,731
+85% +$749K 0.18% 136
2020
Q4
$771K Buy
+4,410
New +$762K 0.09% 208
2020
Q3
Sell
-4,410
Closed -$629K 345
2020
Q2
$629K Buy
4,410
+2,531
+135% +$350K 0.09% 210
2020
Q1
$204 Buy
+1,879
New +$271K 0.01% 355

Other funds holding LH

NWAM LLC's LH Position: Q2 2026 in Review

NWAM LLC increased its Labcorp (LH) stake by 11% in Q2 2026, buying an estimated $27.1K and bringing the position to 1,078 shares worth $302K. The position accounts for 0.02% of the portfolio, ranked #562.

NWAM LLC first reported a position in LH in Q1 2020 and has held it in 10 quarters since. The position peaked at $2.17M in Q4 2021. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • NWAM LLC held 1,078 shares of Labcorp worth $302K as of Q2 2026.
  • NWAM LLC bought 103 Labcorp shares in Q2 2026, an estimated $27.1K.
  • Labcorp made up 0.02% of NWAM LLC's portfolio in Q2 2026, its #562 holding.
  • NWAM LLC first reported a position in Labcorp in Q1 2020 and has held it in 10 quarters since.
  • NWAM LLC's Labcorp position peaked at $2.17M in Q4 2021.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.